Herbal Drinks for Heathly

( 28 May 2022 ) AstraZeneca vaccine may increase risk of serious neurological condition Souce Scientists believe the jab’s Trojan horse delivery system could be causing a rise in Guillain-Barré syndrome

( 2022.04.28. ) Evidence for Aerosol Transfer of SARS-CoV2-specific Humoral Immunity Souce Despite the obvious knowledge that infectious particles can be shared through respiration, whether other constituents

Antigen antibody complex Meer This report was published via Actifit app (Android | iOS). Check out the original version here on actifit.io 28/03/2022 5401 Daily Activity

Prior to the release of data from the Moderna and Pfizer Phase III clinical trials (as well as the large accumulation of data since the vaccines were authorized under the EUA), there was widespread glurge

Several studies have shown that those who have been infected with covid tend to have a stronger antibody response to vaccination. This is compared to people who have no prior infection and get the jab.

This study by Moderna correlates antibody levels in their COVE trial participants on day 57 (counting from the first dose) with vaccine efficacy from day 57 to day 100. This study is similar to a study

A large medical center in Israel had previously done a study in which they took blood samples from employees to measure antibody levels at intervals after vaccination with Pfizer. Subsequently, 39 fully

Today J&J released an 8-month update study in a small subset of trial participants (8 people), including information on the delta variant. They chose an older subset ranging in age from 47-91, in order

It was supposed to start this coming week, but Pfizer is shifting it to the following week in order to get their paperwork in order. As I mentioned before, the design of the study is to give 10,000 people

I have been waiting for a long time for the companies running the vaccine trials to release data on what antibody level is protective. They took blood samples after the second shot, and have been monitoring

I've been doing some reading about breakthrough infections with vaccines to other viruses. The ones that I found the most data on were hepatitis B and E. The Hep B virus is transmitted mostly by contact

Sometimes different groups of scientists do similar experiments and come up with different results and different conclusions. For people who have an authoritarian view of science, this can be distressing,

This one is going to take some explaining, but it is relevant for the search to figure out what level of antibodies is protective. The study measured antibody levels over time in dental health care workers

The UK is monitoring reinfections in a group of 9813 health care workers with prior infection. In order to count as a potential reinfection, they must have a second positive PCR test more than 90 days

A long-lived antibody response requires that B-cells become activated in lymph nodes, develop first into plasmablasts, and then finally into plasma cells, which live in the bone marrow rather than the

This study is similar to many others that have showed that people with prior infection have a much better antibody response to vaccination than do those with no prior exposure to the virus. The thing that

In order to get high levels of long-lasting antibodies, you need a good CD4+ T-cell response. These are also called helper T-cells and are the cells that are killed by HIV. When their levels dip too low,

One of the unexpected bonuses of participating in a vaccine trial was finding an online community of like-minded fellow trial participants. As you might imagine, science nerds are over-represented in these

Link to study: This is a really interesting study on an aspect of immunity to SARS CoV-2 that to my knowledge has not been examined anywhere else. While we have seen many studies on virus neutralization